688336.SH
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 32.36
+0.94%Oct 22, 2026, 09:31 UTC
3SBio reported first-three-quarter 2026 revenue of CNY 1.392 billion, attributable net profit of CNY 587 million and adjusted net profit of CNY 442 million.
Source:Oct 22, 2026, 09:31 UTC
3SBio reported third-quarter 2026 revenue of CNY 527 million, attributable net profit of CNY 216 million and adjusted net profit of CNY 183 million.
Source:Jul 30, 2026, 13:21 UTC
Controlling shareholder Zhang Yushuai purchased 1.4514 million H-shares of Dongyangguang Pharmaceutical in the open market from July 24 to 30, 2026, for a total consideration of about 56 million yuan.
Source:Jul 28, 2026, 11:43 UTC
Sunshine Nuohe's wholly-owned subsidiary Nuohe Shengtai received a Drug Clinical Trial Approval Notice from the National Medical Products Administration for its STC009 injection.
Source: